Celldex Therapeutics, Inc. (CLDX)
NASDAQ: CLDX · Real-Time Price · USD
25.02
-0.38 (-1.48%)
Nov 5, 2024, 1:19 PM EST - Market open

Celldex Therapeutics Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2018 - 2014
Period Ending
Jun '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2018 - 2014
Revenue
8.36.882.364.657.423.57
Upgrade
Revenue Growth (YoY)
155.16%192.02%-49.32%-37.30%107.61%-62.54%
Upgrade
Cost of Revenue
120.94118.0182.2653.3142.5342.67
Upgrade
Gross Profit
-112.64-111.13-79.9-48.66-35.12-39.1
Upgrade
Selling, General & Admin
35.2830.9127.220.4914.4615.43
Upgrade
Operating Expenses
50.6630.9127.220.4914.4615.43
Upgrade
Operating Income
-163.29-142.04-107.1-69.15-49.57-54.53
Upgrade
Interest & Investment Income
25.5813.112.910.512.414.15
Upgrade
EBT Excluding Unusual Items
-137.72-128.93-104.19-68.64-47.17-50.37
Upgrade
Gain (Loss) on Sale of Investments
------1.8
Upgrade
Legal Settlements
-12.5-12.5-15---
Upgrade
Other Unusual Items
--6.861.414.221.29
Upgrade
Pretax Income
-150.22-141.43-112.33-70.74-60.95-50.88
Upgrade
Income Tax Expense
----0.23-1.17-
Upgrade
Net Income
-150.22-141.43-112.33-70.51-59.78-50.88
Upgrade
Net Income to Common
-150.22-141.43-112.33-70.51-59.78-50.88
Upgrade
Shares Outstanding (Basic)
564847433015
Upgrade
Shares Outstanding (Diluted)
564847433015
Upgrade
Shares Change (YoY)
18.94%3.33%9.37%44.64%104.32%38.93%
Upgrade
EPS (Basic)
-2.68-2.92-2.40-1.64-2.02-3.51
Upgrade
EPS (Diluted)
-2.68-2.92-2.40-1.64-2.02-3.51
Upgrade
Free Cash Flow
-122.93-109.11-105.56-62.16-41.96-47.15
Upgrade
Free Cash Flow Per Share
-2.19-2.25-2.25-1.45-1.42-3.25
Upgrade
Operating Margin
-1966.65%-2063.66%-4543.74%-1486.73%-668.27%-1526.03%
Upgrade
Profit Margin
-1809.18%-2054.76%-4765.59%-1516.04%-805.88%-1423.96%
Upgrade
Free Cash Flow Margin
-1480.57%-1585.20%-4478.57%-1336.44%-565.60%-1319.51%
Upgrade
EBITDA
-160.19-139.03-104.2-66.08-45.64-49.67
Upgrade
D&A For EBITDA
3.13.012.93.073.934.86
Upgrade
EBIT
-163.29-142.04-107.1-69.15-49.57-54.53
Upgrade
Revenue as Reported
8.36.882.364.657.423.57
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.